SZSE Ticker: 000504

Nanhua Bio-Medicine Co., Ltd.

南华生物医药股份有限公司

ST生物

CMI

Listing Date: 1992-12-08

Board: Main Board - A Shares

Industry Classification: Research & Development

Prospects of the USDA report on U.S. soybeans in May and the framework and outlook for U.S. drought research

Post date May 8, 2022 — 18:37 Post Lock

Nanhua Bio focuses on its main business, promotes scientific research and builds an internationalized high-end R&D matrix

Post date May 8, 2022 — 18:30 Post Lock

Nanhua Bio focuses on its main business to promote scientific research and build an international high-end R&D matrix-ZAKER News

Post date May 7, 2022 — 19:50 Post Lock

176 shares of financing balance increased by more than 5% _ Oriental Fortune Net

Post date May 6, 2022 — 10:30 Post Lock

Nanhua Bio received a reply from the China Red Foundation, and the "Boai Grassroots Public Health Aid Project" is expected to accelerate-

Post date April 17, 2022 — 23:26 Post Lock

Nanhua Bio received a reply from the China Red Foundation, and the "Boai Grassroots Public Health Aid Project" is expected to accelerate

Post date April 17, 2022 — 22:08 Post Lock

Nanhua Biological (000504.SZ): Received a reply letter from the Chinese Red Cross Foundation on the five-year development strategic plan of the fraternity grassroots public health assistance program_Individual Stock Information_Market Gold Online

Post date April 17, 2022 — 18:30 Post Lock

Nanhua Biotech (000504): Nanhua Biotech's independent director obtained independent director qualification certificate CFi.CN Zhongcai Network

Post date April 9, 2022 — 04:57 Post Lock

Zhao Yaqing, independent director of Nanhua Biotechnology (000504.SZ), obtained the qualification certificate of independent director_Individual Stock Information_Market Gold Online

Post date April 8, 2022 — 22:16 Post Lock

Zhao Yaqing, independent director of Nanhua Biotechnology, obtained the qualification certificate of independent director

Post date April 8, 2022 — 22:02 Post Lock